The Use of Sodium Enoxaparin in the Treatment of Tinnitus

International Tinnitus Journal

Volumn 9, Issue 2, 2003, Pages 109-111

  Mora, Renzo ^a,b   Salami, Angelo ^a   Barbieri, Marco ^a   Mora, Francesco ^a   Passali, Giulio Cesare ^a   Capobianco, Saverio ^a   Magnan, Jacques ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE   (Italy)

Author keywords

Microthrombotic factors; Sodium enoxaparin; Tinnitus

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; ENOXAPARIN; MULTIVITAMIN; VASOACTIVE AGENT;

ACOUSTICS; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG ACTIVITY; HEARING IMPAIRMENT; HUMAN; MICROTHROMBUS; PATHOLOGY; PRIORITY JOURNAL; SIDE EFFECT; TINNITUS; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTICOAGULANTS; ENOXAPARIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; REGRESSION ANALYSIS; TINNITUS; TREATMENT OUTCOME;

EID: 1642576327     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ryedberg EJ, Westfall JM, Nicholas RA. Low-molecular-weight heparin in preventing and treating DVT. Am Fam Phys 59:1607-1612, 1999.
2. Depasse F, Samama MM. Heparin-induced thrombocytopenia. Ann Biol Clin (Paris) 58:317-326, 2000.
3. Drew PI, Smith MJ, Milling MA. Heparin-induced skin necrosis and low molecular weight heparins. Ann R Coll Surg Engl 1999;81:266-269.
4. Wutschert R, Piletta P, Bounameaux H. Adverse skin reactions to low molecular weight heparins: Frequency, management and prevention. Drug Saf 20:515-525, 1999.
5. Kaul S, Shah PK. Low molecular weight heparin in acute coronary syndrome: Evidence for superior or equivalent efficacy compared with unfractionated heparin. J Am Coll Cardiol 35:1699-1712, 2000.
6. Antman EM, Kereiakes DJ. Antithrombotic therapy in unstable angina/ non-ST elevation myocardial infarction: The evolving role of low-molecular-weight heparin. J Invasive Cardiol 12(suppl E):E1-E4; discussion E25-E28, 2000.
7. Fabris F, Ahmad S, Cella G, et al. Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications-a review. Arch Pathol Lab Med 124:1657-1666, 2000.
8. Fabris F, Luzzatto G, Stefani PM, et al. Heparin-induced thrombocytopenia. Haematologica 85:72-81, 2000.
9. Achilli E, Cortinovis A, Ardemagni P, Crippa A. Rheologic modifications induced by heparin therapy. Capillary blood viscosity, erythrocyte deformability, aggregation index. Minerva Cardioangiol 47:95-119, 1999.
10. van den Belt AG, Prins MH, Lensing AW, et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2000.
11. Chan WS, Ray JG. Low molecular weight heparin use during pregnancy: Issues of safety and practicality. Obstet Gynecol Surv 54:649-654, 1999.
12. Tyrrell DJ, Home AP, Holme KR, et al. Heparin in inflammation: Potential therapeutic applications beyond anticoagulation. Adv Pharmacol 46:151-208, 1999.